TAK-019
TAK-019-3001
Phase 3 mab completed
Quick answer
TAK-019 for Coronavirus Disease (COVID-19) is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Coronavirus Disease (COVID-19)
- Phase
- Phase 3
- Modality
- mab
- Status
- completed